TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. scores highest on Torque (61) and lowest on Nitro (15). Its PosiPenta is 39.82 out of 100, weaker than most similar companies.
On the Penta Grid this week, TransCode Therapeutics, Inc. is Grid #547 of 837 in the Healthcare sector in United States, and Grid #2,903 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| TransCode Therapeutics, Inc. | 39.82 | 49 | 40 | 15 | 61 | 34 |
| Nortech Systems Incorporated | 59.19 | 63 | 79 | 59 | 54 | 41 |
| OneMedNet Corporation | 41.02 | 0 | 38 | 21 | 93 | 53 |
| Rockwell Medical, Inc. | 50.57 | 41 | 62 | 58 | 51 | 41 |
| CEL-SCI Corporation | 26.87 | 22 | 20 | 27 | 18 | 47 |
| Milestone Scientific Inc. | 39.72 | 8 | 52 | 57 | 34 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.03 |
| P/B ratio | 0.21 |
EEarnings
| Trailing EPS | ₹-4930.86 |
| Forward EPS | ₹-56.83 |
NNitro
| Price | 161.02 |
| 52-week high | 1457.76 |
| 52-week low | 143.97 |
| Fall from 52-week high | 89.0% |
TTorque
| Return on equity (ROE) | -59.28% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.26 |
| Market cap | ₹272 Cr |
| Insider holding | 1.78% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is TransCode Therapeutics, Inc.'s PosiPenta score?
TransCode Therapeutics, Inc.'s PosiPenta is 39.82 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does TransCode Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, TransCode Therapeutics, Inc. is Grid #547 of 837 in the Healthcare sector in United States, and Grid #2,903 of 4,000 in United States.
Which PosiPenta pillar is strongest for TransCode Therapeutics, Inc.?
Torque (durability), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for TransCode Therapeutics, Inc.?
Nitro (momentum), with a score of 15 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.